• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶 B 和 L 在肿瘤细胞中的活性水平是反映呼肠孤病毒介导的肿瘤细胞杀伤效果的生物标志物。

Activity levels of cathepsins B and L in tumor cells are a biomarker for efficacy of reovirus-mediated tumor cell killing.

机构信息

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.

1] Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan [2] Laboratory of Hepatic Differentiation Research, National Institute of Biomedical Innovation, Osaka, Japan [3] Center for Advanced Medical Engineering and Informatics, Osaka University, Osaka, Japan [4] Laboratory of iPS Research, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.

出版信息

Cancer Gene Ther. 2015 Mar;22(4):188-97. doi: 10.1038/cgt.2015.4. Epub 2015 Jan 30.

DOI:10.1038/cgt.2015.4
PMID:25633482
Abstract

Reovirus has gained much attention as an anticancer agent; however, the mechanism of the tumor cell-specific replication of reovirus is not fully understood. Although Ras activation is known to be crucial for tumor cell-specific replication of reovirus, it remains controversial which cellular factors are required for the reovirus-mediated tumor cell killing. In this study, we systematically investigated which cellular factors determined the efficiencies of reovirus-mediated tumor cell killing in various human cultured cell lines. The efficiency of reovirus-mediated cell killing varied widely among the cell lines. Junction adhesion molecule-A, a reovirus receptor, was highly expressed in almost all cell lines examined. Ras activation levels were largely different between the cell lines; however, there were no apparent correlations among the reovirus-mediated cell killing efficiencies and Ras activation status. On the other hand, activity levels of the cysteine proteases cathepsins B and L, which are crucial for proteolytic disassembly of the outer capsid proteins of reovirus, showed a tendency to be correlated with the efficiency of reovirus-mediated cell killing. These results indicate that the activity of cathepsins B and L is the most suitable as a biomarker for the efficacy of reovirus-mediated oncolysis among the factors examined in this study.

摘要

呼肠孤病毒作为一种抗癌药物引起了广泛关注;然而,呼肠孤病毒对肿瘤细胞的特异性复制的机制尚未完全阐明。虽然 Ras 的激活被认为对呼肠孤病毒对肿瘤细胞的特异性复制至关重要,但对于呼肠孤病毒介导的肿瘤细胞杀伤所需的细胞因子仍存在争议。在这项研究中,我们系统地研究了哪些细胞因子决定了呼肠孤病毒在各种人培养细胞系中介导肿瘤细胞杀伤的效率。呼肠孤病毒介导的细胞杀伤效率在细胞系之间差异很大。连接黏附分子 A 是呼肠孤病毒的受体,几乎在所有检测到的细胞系中都高度表达。Ras 激活水平在细胞系之间有很大的不同;然而,呼肠孤病毒介导的细胞杀伤效率与 Ras 激活状态之间没有明显的相关性。另一方面,半胱氨酸蛋白酶组织蛋白酶 B 和 L 的活性水平,这对呼肠孤病毒外壳蛋白的蛋白水解解体至关重要,与呼肠孤病毒介导的细胞杀伤效率呈正相关。这些结果表明,在本研究中检查的因素中,组织蛋白酶 B 和 L 的活性最适合作为呼肠孤病毒介导的溶瘤作用疗效的生物标志物。

相似文献

1
Activity levels of cathepsins B and L in tumor cells are a biomarker for efficacy of reovirus-mediated tumor cell killing.组织蛋白酶 B 和 L 在肿瘤细胞中的活性水平是反映呼肠孤病毒介导的肿瘤细胞杀伤效果的生物标志物。
Cancer Gene Ther. 2015 Mar;22(4):188-97. doi: 10.1038/cgt.2015.4. Epub 2015 Jan 30.
2
Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells.组织蛋白酶L和组织蛋白酶B介导呼肠孤病毒在小鼠成纤维细胞中的解体。
J Biol Chem. 2002 Jul 5;277(27):24609-17. doi: 10.1074/jbc.M201107200. Epub 2002 May 1.
3
Cationic liposome-mediated delivery of reovirus enhances the tumor cell-killing efficiencies of reovirus in reovirus-resistant tumor cells.阳离子脂质体介导的呼肠孤病毒递送增强了呼肠孤病毒在耐药肿瘤细胞中杀伤肿瘤细胞的效率。
Int J Pharm. 2017 May 30;524(1-2):238-247. doi: 10.1016/j.ijpharm.2017.04.006. Epub 2017 Apr 4.
4
Proteolytic disassembly is a critical determinant for reovirus oncolysis.蛋白水解拆解是呼肠孤病毒溶瘤作用的关键决定因素。
Mol Ther. 2007 Aug;15(8):1512-21. doi: 10.1038/sj.mt.6300207. Epub 2007 May 22.
5
Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly.在持续的呼肠孤病毒感染过程中选择的突变细胞不表达成熟的组织蛋白酶L,也不支持呼肠孤病毒的解体。
J Virol. 1999 Nov;73(11):9532-43. doi: 10.1128/JVI.73.11.9532-9543.1999.
6
Proteolytic disassembly of viral outer capsid proteins is crucial for reovirus-mediated type-I interferon induction in both reovirus-susceptible and reovirus-refractory tumor cells.病毒外衣壳蛋白的蛋白水解拆卸对于呼肠孤病毒介导的I型干扰素诱导在呼肠孤病毒易感和呼肠孤病毒难治性肿瘤细胞中都至关重要。
Biomed Res Int. 2015;2015:468457. doi: 10.1155/2015/468457. Epub 2015 Mar 19.
7
Addition of exogenous protease facilitates reovirus infection in many restrictive cells.添加外源性蛋白酶可促进呼肠孤病毒在许多限制性细胞中的感染。
J Virol. 2002 Aug;76(15):7430-43. doi: 10.1128/jvi.76.15.7430-7443.2002.
8
Sequence polymorphisms in the reovirus σ1 attachment protein modulate encapsidation efficiency and replication in mice.呼肠孤病毒σ1附着蛋白中的序列多态性调节小鼠体内的衣壳化效率和复制。
J Virol. 2024 Jun 13;98(6):e0030524. doi: 10.1128/jvi.00305-24. Epub 2024 May 21.
9
Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis.组织蛋白酶表达的基因和药理学改变影响呼肠孤病毒的发病机制。
J Virol. 2009 Oct;83(19):9630-40. doi: 10.1128/JVI.01095-09. Epub 2009 Jul 29.
10
Molecular determinants of proteolytic disassembly of the reovirus outer capsid.病毒外核蛋白的蛋白水解解体的分子决定因素。
J Biol Chem. 2012 Mar 9;287(11):8029-38. doi: 10.1074/jbc.M111.334854. Epub 2012 Jan 17.

引用本文的文献

1
Tumor-specific biochemical nanoconversion of self-assembled peptide-conjugated paclitaxel-docetaxel-based nanoparticles.基于自组装肽共轭紫杉醇-多西他赛的纳米颗粒的肿瘤特异性生化纳米转化
Nano Converg. 2025 Apr 26;12(1):20. doi: 10.1186/s40580-025-00487-0.
2
Human Melanoma and Glioblastoma Cells Express Cathepsins Supporting Reovirus Moscow Strain Infection.人类黑色素瘤细胞和胶质母细胞瘤细胞表达组织蛋白酶,支持呼肠孤病毒莫斯科株感染。
Viruses. 2024 Dec 19;16(12):1944. doi: 10.3390/v16121944.
3
Oncolytic virotherapy in cancer treatment: challenges and optimization prospects.

本文引用的文献

1
The Nogo receptor NgR1 mediates infection by mammalian reovirus.诺戈受体NgR1介导呼肠孤病毒的感染。
Cell Host Microbe. 2014 Jun 11;15(6):681-91. doi: 10.1016/j.chom.2014.05.010.
2
Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults.瘤内注射呼肠孤病毒治疗成人复发性恶性胶质瘤的1期临床试验。
Mol Ther. 2014 May;22(5):1056-62. doi: 10.1038/mt.2014.21. Epub 2014 Feb 20.
3
Oncolytic reovirus in canine mast cell tumor.溶瘤呼肠孤病毒治疗犬肥大细胞瘤。
肿瘤溶瘤病毒治疗癌症:挑战与优化前景。
Front Immunol. 2023 Dec 15;14:1308890. doi: 10.3389/fimmu.2023.1308890. eCollection 2023.
4
Involvement of Protein Kinase R in Double-Stranded RNA-Induced Proteasomal Degradation of Hypoxia Inducible Factor-1α.蛋白激酶 R 参与双链 RNA 诱导的缺氧诱导因子-1α 的蛋白酶体降解。
Inflammation. 2023 Dec;46(6):2332-2342. doi: 10.1007/s10753-023-01881-8. Epub 2023 Aug 24.
5
Modulation of Reoviral Cytolysis (II): Cellular Stemness.病毒溶细胞性的调节(二):细胞干性。
Viruses. 2023 Jun 29;15(7):1473. doi: 10.3390/v15071473.
6
Evolving Role of Oncolytic Virotherapy: Challenges and Prospects in Clinical Practice.溶瘤病毒治疗的发展演变:临床实践中的挑战与展望。
JCO Precis Oncol. 2021 Feb 24;5. doi: 10.1200/PO.20.00395. eCollection 2021.
7
Cathepsin B-Responsive Liposomes for Controlled Anticancer Drug Delivery in Hep G2 Cells.用于在肝癌细胞系Hep G2中实现可控抗癌药物递送的组织蛋白酶B响应性脂质体
Pharmaceutics. 2020 Sep 14;12(9):876. doi: 10.3390/pharmaceutics12090876.
8
Quantitative Proteome Responses to Oncolytic Reovirus in GM-CSF- and M-CSF-Differentiated Bone Marrow-Derived Cells.GM-CSF和M-CSF分化的骨髓源细胞对溶瘤呼肠孤病毒的定量蛋白质组反应
J Proteome Res. 2020 Feb 7;19(2):708-718. doi: 10.1021/acs.jproteome.9b00583. Epub 2020 Jan 17.
9
Breast Tumor-Associated Metalloproteases Restrict Reovirus Oncolysis by Cleaving the σ1 Cell Attachment Protein and Can Be Overcome by Mutation of σ1.肿瘤相关金属蛋白酶通过切割 σ1 细胞附着蛋白来限制呼肠孤病毒的溶瘤作用,并且可以通过突变 σ1 来克服。
J Virol. 2019 Oct 29;93(22). doi: 10.1128/JVI.01380-19. Print 2019 Nov 15.
10
Systemically Administered Reovirus-Induced Downregulation of Hypoxia Inducible Factor-1α in Subcutaneous Tumors.全身给药的呼肠孤病毒诱导皮下肿瘤中缺氧诱导因子-1α的下调。
Mol Ther Oncolytics. 2018 Dec 31;12:162-172. doi: 10.1016/j.omto.2018.12.012. eCollection 2019 Mar 29.
PLoS One. 2013 Sep 20;8(9):e73555. doi: 10.1371/journal.pone.0073555. eCollection 2013.
4
Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer.雷奥霉素是一种新型的呼肠孤病毒制剂,可诱导胰腺癌内质网应激介导的细胞凋亡。
Cell Death Dis. 2013 Jul 18;4(7):e728. doi: 10.1038/cddis.2013.259.
5
TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.TGF-β 信号通路、激活的基质成纤维细胞以及半胱氨酸组织蛋白酶 B 和 L 驱动人黑色素瘤细胞的侵袭性生长。
Am J Pathol. 2012 Dec;181(6):2202-16. doi: 10.1016/j.ajpath.2012.08.027. Epub 2012 Oct 10.
6
Reovirus: a targeted therapeutic--progress and potential.呼肠孤病毒:一种有针对性的治疗药物——进展与潜力。
Mol Cancer Res. 2012 Dec;10(12):1514-25. doi: 10.1158/1541-7786.MCR-12-0157. Epub 2012 Oct 4.
7
TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles.TRAIL 和 Noxa 在 RIG-I/MAVS 信号通路下游受非复制性仙台病毒颗粒的调节选择性地上调表达于前列腺癌细胞中。
Clin Cancer Res. 2012 Nov 15;18(22):6271-83. doi: 10.1158/1078-0432.CCR-12-1595. Epub 2012 Sep 26.
8
Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.呼肠孤病毒在头颈部癌细胞系中发挥强大的溶瘤作用,而不依赖于 EGFR 通路中的信号转导。
BMC Cancer. 2012 Aug 24;12:368. doi: 10.1186/1471-2407-12-368.
9
Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma.静脉注射 Reolysin(®)(Reovirus Serotype-3-dearing Strain)治疗转移性黑色素瘤患者的 II 期临床试验。
Mol Ther. 2012 Oct;20(10):1998-2003. doi: 10.1038/mt.2012.146. Epub 2012 Aug 7.
10
Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies.卡铂和紫杉醇化疗联合静脉注射溶瘤单纯疱疹病毒治疗晚期恶性肿瘤的 I/II 期临床试验。
Clin Cancer Res. 2012 Apr 1;18(7):2080-9. doi: 10.1158/1078-0432.CCR-11-2181. Epub 2012 Feb 7.